Adjuvant Trastuzumab Is Required in Human Epidermal Growth Factor Receptor 2-Positive Node-Negative Breast Cancer Patients Regardless of Tumour Size.
Laura Bender SommeJean-Emmanuel KurtzThierry PetitXavier PivotPublished in: Journal of breast cancer (2020)